Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
25
QSI Quote, Financials, Valuation and Earnings
Last price:
$1.23
Seasonality move
:
-8.7%
Day range:
$1.22 - $1.31
52-week range:
$0.95 - $5.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
69.81x
P/B ratio:
1.13x
Volume:
4.2M
Avg. volume:
4.6M
1-year change:
-42.79%
Market cap:
$265.1M
Revenue:
$3.1M
EPS (TTM):
-$0.66
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
$599.3K | -$0.12 | -36.07% | -42.58% | $2.68 |
|
CATX
Perspective Therapeutics, Inc.
|
$147K | -$0.35 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$806.3K | -$0.04 | 272.5% | -33.67% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$28.5M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
$1.23 | $2.68 | $265.1M | -- | $0.00 | 0% | 69.81x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8800 | $12.3077 | $214.1M | -- | $0.00 | 0% | 195.28x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.25 | $2.20 | $30.7M | -- | $0.00 | 0% | 17.13x |
|
VTAK
Catheter Precision, Inc.
|
$1.68 | -- | $2.1M | 0.40x | $0.00 | 0% | 7.90x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.78 | $1.50 | $108.6M | 76.08x | $0.00 | 0% | 0.85x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
1.92% | 1.064 | 1.52% | 10.24x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
QSI
Quantum-Si, Inc.
|
-$979K | -$24.4M | -49.36% | -51.75% | -4419.57% | -$32.9M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Quantum-Si, Inc. vs. Competitors
-
Which has Higher Returns QSI or CATX?
Perspective Therapeutics, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -12425.36%. Quantum-Si, Inc.'s return on equity of -51.75% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About QSI or CATX?
Quantum-Si, Inc. has a consensus price target of $2.68, signalling upside risk potential of 118.16%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 327.35%. Given that Perspective Therapeutics, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is QSI or CATX More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock QSI or CATX?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or CATX?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Quantum-Si, Inc.'s net income of -$35.7M is lower than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 69.81x versus 195.28x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.69.81x -- $552K -$35.7M CATXPerspective Therapeutics, Inc.195.28x -- $209K -$26M
-
Which has Higher Returns QSI or PMI?
Picard Medical has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of --. Quantum-Si, Inc.'s return on equity of -51.75% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M PMIPicard Medical-- -- -- -
What do Analysts Say About QSI or PMI?
Quantum-Si, Inc. has a consensus price target of $2.68, signalling upside risk potential of 118.16%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Quantum-Si, Inc. has higher upside potential than Picard Medical, analysts believe Quantum-Si, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 PMIPicard Medical0 0 0 -
Is QSI or PMI More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock QSI or PMI?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or PMI?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Picard Medical quarterly revenues of --. Quantum-Si, Inc.'s net income of -$35.7M is higher than Picard Medical's net income of --. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 69.81x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.69.81x -- $552K -$35.7M PMIPicard Medical-- -- -- --
-
Which has Higher Returns QSI or VNRX?
VolitionRX Ltd. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -862.39%. Quantum-Si, Inc.'s return on equity of -51.75% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About QSI or VNRX?
Quantum-Si, Inc. has a consensus price target of $2.68, signalling upside risk potential of 118.16%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 780%. Given that VolitionRX Ltd. has higher upside potential than Quantum-Si, Inc., analysts believe VolitionRX Ltd. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 VNRXVolitionRX Ltd.4 2 0 -
Is QSI or VNRX More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock QSI or VNRX?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or VNRX?
Quantum-Si, Inc. quarterly revenues are $552K, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Quantum-Si, Inc.'s net income of -$35.7M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 69.81x versus 17.13x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.69.81x -- $552K -$35.7M VNRXVolitionRX Ltd.17.13x -- $627.3K -$5.4M
-
Which has Higher Returns QSI or VTAK?
Catheter Precision, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of -1037.17%. Quantum-Si, Inc.'s return on equity of -51.75% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About QSI or VTAK?
Quantum-Si, Inc. has a consensus price target of $2.68, signalling upside risk potential of 118.16%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2161.97%. Given that Catheter Precision, Inc. has higher upside potential than Quantum-Si, Inc., analysts believe Catheter Precision, Inc. is more attractive than Quantum-Si, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 VTAKCatheter Precision, Inc.0 0 0 -
Is QSI or VTAK More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock QSI or VTAK?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or VTAK?
Quantum-Si, Inc. quarterly revenues are $552K, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Quantum-Si, Inc.'s net income of -$35.7M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 69.81x versus 7.90x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.69.81x -- $552K -$35.7M VTAKCatheter Precision, Inc.7.90x 0.40x $226K -$2.3M
-
Which has Higher Returns QSI or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -6467.94% compared to Quantum-Si, Inc.'s net margin of 3.93%. Quantum-Si, Inc.'s return on equity of -51.75% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital QSIQuantum-Si, Inc.-177.36% -$0.17 $239.8M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About QSI or XTNT?
Quantum-Si, Inc. has a consensus price target of $2.68, signalling upside risk potential of 118.16%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 93.3%. Given that Quantum-Si, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Quantum-Si, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings QSIQuantum-Si, Inc.2 1 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is QSI or XTNT More Risky?
Quantum-Si, Inc. has a beta of 2.983, which suggesting that the stock is 198.267% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock QSI or XTNT?
Quantum-Si, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quantum-Si, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios QSI or XTNT?
Quantum-Si, Inc. quarterly revenues are $552K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Quantum-Si, Inc.'s net income of -$35.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Quantum-Si, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quantum-Si, Inc. is 69.81x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income QSIQuantum-Si, Inc.69.81x -- $552K -$35.7M XTNTXtant Medical Holdings, Inc.0.85x 76.08x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
